1. Home
  2. CALC vs LITB Comparison

CALC vs LITB Comparison

Compare CALC & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • LITB
  • Stock Information
  • Founded
  • CALC 2011
  • LITB 2007
  • Country
  • CALC United States
  • LITB Singapore
  • Employees
  • CALC N/A
  • LITB N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • LITB Catalog/Specialty Distribution
  • Sector
  • CALC Health Care
  • LITB Consumer Discretionary
  • Exchange
  • CALC Nasdaq
  • LITB Nasdaq
  • Market Cap
  • CALC 22.9M
  • LITB 20.5M
  • IPO Year
  • CALC N/A
  • LITB N/A
  • Fundamental
  • Price
  • CALC $1.58
  • LITB $1.16
  • Analyst Decision
  • CALC Strong Buy
  • LITB
  • Analyst Count
  • CALC 3
  • LITB 0
  • Target Price
  • CALC $16.33
  • LITB N/A
  • AVG Volume (30 Days)
  • CALC 28.9K
  • LITB 10.6K
  • Earning Date
  • CALC 08-11-2025
  • LITB 08-01-2025
  • Dividend Yield
  • CALC N/A
  • LITB N/A
  • EPS Growth
  • CALC N/A
  • LITB N/A
  • EPS
  • CALC N/A
  • LITB 0.08
  • Revenue
  • CALC N/A
  • LITB $231,136,000.00
  • Revenue This Year
  • CALC N/A
  • LITB N/A
  • Revenue Next Year
  • CALC N/A
  • LITB N/A
  • P/E Ratio
  • CALC N/A
  • LITB $15.16
  • Revenue Growth
  • CALC N/A
  • LITB N/A
  • 52 Week Low
  • CALC $1.42
  • LITB $0.91
  • 52 Week High
  • CALC $5.97
  • LITB $5.70
  • Technical
  • Relative Strength Index (RSI)
  • CALC 44.94
  • LITB 45.65
  • Support Level
  • CALC $1.42
  • LITB $1.11
  • Resistance Level
  • CALC $1.85
  • LITB $1.25
  • Average True Range (ATR)
  • CALC 0.15
  • LITB 0.09
  • MACD
  • CALC -0.01
  • LITB 0.01
  • Stochastic Oscillator
  • CALC 37.21
  • LITB 34.00

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: